The Therapeutic Goods Administration's (TGA) warning covers the following glucagon-like peptide-1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and obesity: Semaglutide, sold as Ozempic, Wegovy Tirzepatide, sold as Mounjaro Dulaglutide, sold as Trulicity Liraglutide, sold as Saxenda The TGA said the products had the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION)
People with moderate to severe kidney problems get this condition more often than those without kidney issues
Statements about dietary supplements have not been evaluated by the Food and Drug Administration (FDA)
Dexcom Flex reflects the companys commitment to placing people at the centre of the product design process and creates a personalised diabetes guidance experience, rather than offering a one-size-fits-all approach
913.33 Sale price From Rs
Whether you're looking to fight the signs of aging, improve hair growth, or strengthen brittle nails, Glowsim Tablets are your perfect daily beauty companion